戻る
BioInvent International AB (publ) (BOVNF) 財務
BOVNF 株価推移チャート
BOVNF 財務
BioInvent International AB (publ)
$3.28
0%
$0
終値： Mar 24, 16:00:00 GMT-4
$3.28
0%
$0
プレマーケット： Mar 25, 09:19:05 GMT-4
主要データ
前終値
$3.28
始値
$4.7
当日レンジ
$3.28 - $4.7
52週レンジ
$3.28 - $4.7
取引高
908
平均取引高
0
配当利回り
--
1株当たり利益(TTM)
-0.47
時価総額
$216.4M
BIOINVENT INTERNATIONAL ABとは何ですか？
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. The company is headquartered in Lund, Skane and currently employs 109 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.